New study reveals molecular mechanism in Alzheimer’s disease

A research team at the Institute of Neurosciences of the University of Barcelona (UBneuro) has led a study describing a new molecular mechanism that affects RNA processing and alters the process of protein synthesis in the brains of Alzheimer’s patients.

Hollywood and Psychiatrists: From Professor Plum to Dr. Melfi

Since the beginning, psychiatrists have had a role in movies and TV — playing roles across genres and far outside their professional remit. Not only

January 25, 2024

Immutep’s LAG-3 drug scores in Phase 2b head and neck cancer test

Immutep’s protein-based cancer treatment has succeeded in a mid-stage study in patients with head and neck squamous cell carcinoma, spurring discussions with regulators on a

July 13, 2024

Innovative insights into effects of hematopoietic changes on colon cancer, unveiling therapeutic avenues

Researchers investigated whether bone marrow-derived cells contribute to colitis-associated colon cancer.

August 29, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.